|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-2-23
|
|
pubmed:abstractText |
To further understand the role of angiogenic growth factors in the development of cerebral cavernous malformations (CCMs) and arteriovenous malformations (AVMs), we investigated endothelial cell (EC) expression of receptors for vascular endothelial growth factor (VEGF) and angiopoietin systems in patients with surgically resected lesions.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Matrix Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/FLT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, TIE-1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, TIE-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, TIE,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vascular Endothelial...,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0148-396X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
359-67; discussion 367-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11220380-Adolescent,
pubmed-meshheading:11220380-Adult,
pubmed-meshheading:11220380-Aged,
pubmed-meshheading:11220380-Antigens, CD31,
pubmed-meshheading:11220380-Cavernous Sinus,
pubmed-meshheading:11220380-Child,
pubmed-meshheading:11220380-Endothelium, Vascular,
pubmed-meshheading:11220380-Extracellular Matrix Proteins,
pubmed-meshheading:11220380-Female,
pubmed-meshheading:11220380-Humans,
pubmed-meshheading:11220380-Immunohistochemistry,
pubmed-meshheading:11220380-Intracranial Arteriovenous Malformations,
pubmed-meshheading:11220380-Male,
pubmed-meshheading:11220380-Middle Aged,
pubmed-meshheading:11220380-Receptor, TIE-1,
pubmed-meshheading:11220380-Receptor, TIE-2,
pubmed-meshheading:11220380-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:11220380-Receptors, Cell Surface,
pubmed-meshheading:11220380-Receptors, Growth Factor,
pubmed-meshheading:11220380-Receptors, TIE,
pubmed-meshheading:11220380-Receptors, Vascular Endothelial Growth Factor,
pubmed-meshheading:11220380-Reference Values,
pubmed-meshheading:11220380-Vascular Endothelial Growth Factor Receptor-1,
pubmed-meshheading:11220380-von Willebrand Factor
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations.
|
|
pubmed:affiliation |
Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
